PAthwAy of Dyspneic patIent in Emergency (PArADIsE) (PArADIsE)

April 14, 2023 updated by: CHOUIHED Tahar

PAthwAy of Dyspneic patIent in Emergency

This is an observational retrospective single-center study (CHRU of Nancy) in patients cared for acute dyspnea by a medical team of the emergencies of the CHRU of Nancy.

The main purpose of the study is to evaluate the outcome of patients cared for acute dyspnea by a medical team of emergencies of CHRU of Nancy.

Study Overview

Status

Recruiting

Detailed Description

This observational retrospective single-center study will be conducted using data from medical records, acquired as part of usual care, patients cared for acute dyspnea in the last 5 years (from the date of authorization of data processing). About 4,000 patients will be affected, including more than 800 patients with acute heart failure.

Study Type

Observational

Enrollment (Anticipated)

24000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Nancy, France, 54000
        • Recruiting
        • CHRU Nancy - Service des Urgences
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with acute dyspnea cared by a medical team of emergencies of CHRU Nancy in the last 5 years.

Description

Inclusion Criteria:

  • Man or women ≥ 18 years
  • Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy.

Exclusion Criteria:

  • Cardiorespiratory arrest before the care by a medical team of the emergencies of the CHRU of Nancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients with acute dyspnea

Patients with acute dyspnea treated by a medical team of emergencies of CHRU of Nancy.

All patients admitted to the emergencies in the last 5 years matching the inclusion criteria will be evaluated. About 4,000 patients will be affected, including more than 800 patients with acute heart failure. (Figures based on export of ICD X codes (R06.0: Dyspnea) of patients cared in extra-hospital for acute dyspnea (diagnosis Dyspnea + Heart Failure) over the last 5 years).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
All cause in-hospital mortality
Time Frame: in the last 5 years
in the last 5 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Demographic and clinical data of patients cared by a medical team of emergencies
Time Frame: in the last 5 years
in the last 5 years
Duration of total hospitalization (including emergency stay and conventional hospitalization)
Time Frame: in the last 5 years
in the last 5 years
The main diagnosis of the initial hospitalization
Time Frame: in the last 5 years
in the last 5 years
Rate of Brain Natriuretic Peptide (BNP)
Time Frame: in the last 5 years
in the last 5 years
Administration of non-invasive ventilation and / or diuretics and / or nitrates
Time Frame: in the last 5 years
in the last 5 years
Administration time of non-invasive ventilation and / or diuretics and / or nitrates
Time Frame: in the last 5 years
in the last 5 years
Service type admitting the patient after the emergency care (intensive care, cardiology, intensive care cardiology, other ...)
Time Frame: in the last 5 years
in the last 5 years
Admission time in a service after the emergency care
Time Frame: in the last 5 years
in the last 5 years
Mortality and re-hospitalization of included patients
Time Frame: in the last 5 years
in the last 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Nicolas GIRERD, MD, Central Hospital, Nancy, France
  • Principal Investigator: Tahar CHOUIHED, MD, PhD, Central Hospital, Nancy, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

December 1, 2018

Study Completion (Anticipated)

October 25, 2025

Study Registration Dates

First Submitted

June 6, 2016

First Submitted That Met QC Criteria

June 10, 2016

First Posted (Estimate)

June 15, 2016

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 14, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Disease

3
Subscribe